HighTower Advisors LLC trimmed its position in shares of Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 13.8% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 10,051 shares of the biotechnology company’s stock after selling 1,615 shares during the period. HighTower Advisors LLC’s holdings in Axon Enterprise were worth $5,635,000 at the end of the most recent quarter.
Several other hedge funds have also recently bought and sold shares of the company. Creative Financial Designs Inc. ADV bought a new stake in shares of Axon Enterprise during the 4th quarter worth approximately $28,000. Camelot Portfolios LLC bought a new position in Axon Enterprise in the fourth quarter valued at approximately $30,000. AlphaCentric Advisors LLC bought a new position in Axon Enterprise in the fourth quarter valued at approximately $34,000. Darwin Wealth Management LLC acquired a new position in Axon Enterprise during the second quarter valued at approximately $37,000. Finally, Strive Financial Group LLC acquired a new position in Axon Enterprise during the fourth quarter valued at approximately $41,000. 79.08% of the stock is owned by institutional investors.
Insider Transactions at Axon Enterprise
In other Axon Enterprise news, President Joshua Isner sold 13,000 shares of the stock in a transaction dated Friday, June 5th. The stock was sold at an average price of $488.45, for a total value of $6,349,850.00. Following the completion of the transaction, the president directly owned 169,125 shares in the company, valued at approximately $82,609,106.25. This trade represents a 7.14% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Patrick W. Smith sold 20,000 shares of Axon Enterprise stock in a transaction dated Thursday, June 4th. The shares were sold at an average price of $500.00, for a total value of $10,000,000.00. Following the sale, the chief executive officer directly owned 3,060,997 shares in the company, valued at $1,530,498,500. The trade was a 0.65% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 68,989 shares of company stock valued at $36,016,932. 4.20% of the stock is currently owned by corporate insiders.
Axon Enterprise Stock Performance
Axon Enterprise (NASDAQ:AXON – Get Free Report) last announced its quarterly earnings results on Tuesday, August 4th. The biotechnology company reported $1.88 EPS for the quarter, beating analysts’ consensus estimates of $1.84 by $0.04. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%.The company had revenue of $904.39 million during the quarter, compared to analysts’ expectations of $876.42 million. During the same period in the prior year, the company earned $2.12 EPS. Axon Enterprise’s revenue was up 35.3% compared to the same quarter last year. On average, equities analysts expect that Axon Enterprise, Inc will post 2.04 EPS for the current fiscal year.
Wall Street Analyst Weigh In
A number of equities research analysts have weighed in on the company. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $715.00 target price on shares of Axon Enterprise in a report on Thursday, August 6th. Zacks Research cut Axon Enterprise from a “strong-buy” rating to a “hold” rating in a report on Friday, July 10th. Weiss Ratings restated a “hold (c-)” rating on shares of Axon Enterprise in a research report on Wednesday, August 5th. Piper Sandler raised their price objective on Axon Enterprise from $724.00 to $732.00 and gave the company an “overweight” rating in a research note on Thursday, August 6th. Finally, Citizens Jmp reiterated a “market outperform” rating and issued a $700.00 target price on shares of Axon Enterprise in a research report on Thursday, June 25th. Thirteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $730.92.
Read Our Latest Research Report on AXON
Key Axon Enterprise News
Here are the key news stories impacting Axon Enterprise this week:
- Positive Sentiment: Northland Securities raised several future earnings estimates. The firm lifted its FY2027 EPS forecast to $6.49 from $5.53 and increased estimates for Q1–Q4 2027, as well as Q3 2026. The revisions suggest stronger anticipated earnings from Axon’s connected-device, software, AI and public-safety technology businesses.
- Positive Sentiment: Axon raised its 2026 revenue-growth outlook to 32%–34%. Management cited strong momentum in connected devices, international demand, counter-drone products and AI-enabled software, supported by approximately $15.1 billion in future contracted bookings. Axon Enterprise Is Up 17.8% After Raising 2026 Revenue Outlook
- Neutral Sentiment: Recent quarterly results exceeded expectations. Second-quarter revenue increased 35.3% year over year to $904.4 million and topped consensus, while adjusted EPS also beat estimates. However, reported net income and diluted EPS declined, highlighting the trade-off between rapid expansion and near-term profitability. The 5 Most Interesting Analyst Questions From Axon’s Q2 Earnings Call
- Negative Sentiment: Northland reduced its FY2026 EPS forecast to $3.12 from $3.26 and cut its Q4 2026 estimate to $1.29 from $1.55. These downgrades indicate some near-term earnings pressure even though longer-term forecasts improved.
- Negative Sentiment: Insider selling added pressure. A report attributed a 6.5% decline to recent insider sales, which can raise concerns about valuation or management’s view of near-term upside. Axon Enterprise Trading Down Following Insider Selling
- Negative Sentiment: Valuation and margins remain risks. With a very high earnings multiple and reported margin contraction, investors may be demanding clearer evidence that revenue growth will translate into sustained profit growth.
About Axon Enterprise
Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.
Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.
Read More
- Five stocks we like better than Axon Enterprise
- Is Best Buy the AI Winner Hiding in the Electronics Aisle?
- Applied Materials Beat Everything but Wall Street’s Expectations for Margins
- Back From Orbit, Intuitive Machines’ Share Price Enters the Buy Zone
- Texas Roadhouse and Brinker International Have the Recipe Rivals Are Missing
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
